Bank Of New York Mellon Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $2.16 Million - $2.27 Million	-14,912 Reduced 1.47%	1,000,497 $151 Million
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $11.6 Million - $20.4 Million	-139,545 Reduced 12.08%	1,015,409 $148 Million
Q1 2022 May 11, 2022	SELL	$110.08 - $142.92 $4.89 Million - $6.35 Million	-44,441 Reduced 3.71%	1,154,954 $137 Million
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $5.09 Million - $7.58 Million	-51,048 Reduced 4.08%	1,199,395 $165 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $1.85 Million - $2.6 Million	18,715 Added 1.52%	1,250,443 $174 Million
Q2 2021 Aug 11, 2021	BUY	$65.78 - $105.02 $2.93 Million - $4.68 Million	44,535 Added 3.75%	1,231,728 $120 Million
Q1 2021 May 13, 2021	BUY	$64.07 - $91.75 $24.1 Million - $34.5 Million	375,612 Added 46.28%	1,187,193 $81.1 Million
Q4 2020 Feb 09, 2021	BUY	$65.07 - $98.24 $853,523 - $1.29 Million	13,117 Added 1.64%	811,581 $69.6 Million
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $348,513 - $460,138	5,903 Added 0.74%	798,464 $51.9 Million
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $2.65 Million - $6.79 Million	91,467 Added 13.05%	792,561 $57.9 Million
Q1 2020 May 06, 2020	BUY	$27.51 - $57.29 $4.11 Million - $8.57 Million	149,558 Added 27.12%	701,094 $23.9 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $417,017 - $588,375	-10,206 Reduced 1.82%	551,536 $30 Million
Q3 2019 Nov 07, 2019	BUY	$37.38 - $49.47 $603,612 - $798,841	16,148 Added 2.96%	561,742 $23.4 Million
Q2 2019 Aug 12, 2019	BUY	$39.79 - $67.01 $15.3 Million - $25.7 Million	383,594 Added 236.79%	545,594 $23.9 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $847,051 - $1.31 Million	24,538 Added 17.85%	162,000 $8.34 Million
Q4 2018 Feb 11, 2019	SELL	$29.75 - $42.9 $66,312 - $95,624	-2,229 Reduced 1.6%	137,462 $5.08 Million
Q3 2018 Nov 09, 2018	SELL	$32.79 - $43.0 $67,908 - $89,053	-2,071 Reduced 1.46%	139,691 $0
Q2 2018 Aug 06, 2018	BUY	$23.62 - $42.29 $480,997 - $861,193	20,364 Added 16.77%	141,762 $5.6 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $1.76 Million - $2.71 Million	78,477 Added 182.84%	121,398 $3.13 Million
Q4 2017 Feb 09, 2018	BUY	$20.44 - $35.56 $877,305 - $1.53 Million	42,921	42,921 $1.16 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account